Epithalon 100mg Research Peptide
Epithalon (Epitalon, Epithalone) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology under the direction of Professor Vladimir Khavinson. It is based on the active sequence of epithalamin — a polypeptide extract from the pineal gland — and has been studied extensively for telomerase activation, antioxidant effects, and biological aging modulation in preclinical and Russian clinical research spanning more than three decades. This 100mg vial provides research-grade Epithalon at ≥99% purity, HPLC and MS/MS verified per batch.
Research Background
Epithalon is one of the most studied peptides in longevity research. Its most notable proposed mechanism is telomerase activation — published cell culture studies have documented Epithalon-induced increases in telomerase activity in human somatic cells, with associated telomere elongation, positioning it as a research tool for studying telomere biology and replicative senescence. Russian in vivo studies in rodents demonstrated extended median and maximum lifespan in Epithalon-treated groups versus controls. Long-term (up to 15-year) observational studies in elderly humans treated with epithalamin (the parent compound) showed significantly reduced mortality and cancer incidence compared to control groups — one of the most extensive longitudinal datasets available for any research peptide.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 100mg per vial
- Storage: −20°C, protected from light
- Sequence: Ala-Glu-Asp-Gly
- Molecular Weight: 390.3 Da
Certificate of Analysis
All Epithalon vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
